Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Neuronext Clinical Trials (U01 Clinical Trial Optional) in the USA. This Tender notice was published on 06 May 2021 and is scheduled to close on 05 Mar 2024, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 52847004, while the tender notice number is PAR-21-223 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Neuronext Clinical Trials (U01 Clinical Trial Optional)
Deadline: 05 Mar 2024
Posting Date: 06 May 2021
Other Information
Notice Type: Tender
TOT Ref.No.: 52847004
Document Ref. No.: PAR-21-223
Competition: ICB
Financier: Self Financed
Purchaser Ownership: -
Tender Value: Refer Document
CPV Classification
72222300 - Information technology servicesPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details Tender are invited for NeuroNEXT Clinical Trials (U01 Clinical Trial Optional) Documents
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Mar 05, 2024
Posted Date : May 05, 2021
Description: This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol. Applicants do not need to be part of the existing NeuroNEXT infrastructure.
Similar Tenders
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google